Australian Clinical Labs Limited (ASX:ACL)
Australia
· Delayed Price · Currency is AUD 2.200
-0.020 (-0.90%)
At close: Mar 6, 2026
Australian Clinical Labs Revenue
Australian Clinical Labs had revenue of 365.39M AUD in the half year ending December 31, 2025, with 8.34% growth. This brings the company's revenue in the last twelve months to 737.49M, up 1.27% year-over-year. In the fiscal year ending June 30, 2025, Australian Clinical Labs had annual revenue of 741.27M with 6.45% growth.
Revenue (ttm)
737.49M
Revenue Growth
+1.27%
P/S Ratio
0.56
Revenue / Employee
156.91K
Employees
4,700
Market Cap
416.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 741.27M | 44.90M | 6.45% |
| Jun 30, 2024 | 696.37M | -704.00K | -0.10% |
| Jun 30, 2023 | 697.07M | -298.53M | -29.99% |
| Jun 30, 2022 | 995.60M | 348.90M | 53.95% |
| Jun 30, 2021 | 646.70M | 156.13M | 31.83% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Healius | 1.37B |
| Monash IVF Group | 269.39M |
| Integral Diagnostics | 767.82M |
| Cryosite | 15.75M |
| Rhythm Biosciences | 1.65M |
| Microba Life Sciences | 14.90M |
| INOVIQ | 2.10M |
| BCAL Diagnostics | 2.54M |